UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Cancer, 2018-12, Vol.124 (24), p.4618-4621

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Clinical breast cancer, 2019-06, Vol.19 (3), p.188-196

2019

Link zum Volltext

Verfügbarkeit prüfen

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Clinical cancer research, 2021-06, Vol.27 (11), p.3061-3068

2021

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Breast cancer : basic and clinical research, 2009-09, Vol.2009 (3), p.61-75

2009

Link zum Volltext

Verfügbarkeit prüfen

Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry

Nature protocols, 2007-05, Vol.2 (5), p.1152-1165

2007

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like Growth Factor-l-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth

JNCI : Journal of the National Cancer Institute, 1998-10, Vol.90 (20), p.1552-1558

1998

Link zum Volltext

Verfügbarkeit prüfen

Abstract 590: Multiplex liquid biopsy for AR pathway activity in metastatic androgen receptor-positive triple negative breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.590-590

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS5-35: Detection of PI3K pathway activation in circulating tumor cells in PIK3CA mutated metastatic breast cancer as a putative predictive biomarker for PI3K inhibitor therapies

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-35-PS5-35

2021

Link zum Volltext

Verfügbarkeit prüfen

In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots

Advanced materials (Weinheim), 2007-10, Vol.19 (20), p.3146-3151

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-07-07: Combination of IGF1R/FAK inhibition and PI3K/mTOR inhibition in triple-negative breast cancers

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-07-07

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract A07: Spontaneous canine mammary cancers: A much-needed model for human basal-like breast cancer and an ideal system to understand myoepithelial cells

Molecular cancer research, 2016-02, Vol.14 (2_Supplement), p.A07-A07

2016

Link zum Volltext

Verfügbarkeit prüfen

Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy

Breast cancer (Tokyo, Japan), 1998-07, Vol.5 (3), p.211-217

1998

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1955: Simultaneous longitudinal assessment of PIK3CA genomic mutations and PI3K pathway activity in circulating tumor cells in metastatic breast cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1955-1955

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1467: Inhibition of Cdk4 radiosensitizes breast cancer cells by increasing PP2A levels, and decreasing Bad136 phosphorylation

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1467-1467

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2703: Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2703-2703

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-206: Breast cancer 21 -gene recurrence scores: Are there racial disparities in testing, scores, treatment, and outcome

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-206-LB-206

2010

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen to raloxifene and beyond

Seminars in oncology, 2001-06, Vol.28 (3), p.260-273, Article asonc0280260

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT051: Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT051-CT051

2019

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Breast cancer : basic and clinical research, 2009-01, Vol.3

2009

Link zum Volltext

Verfügbarkeit prüfen

Goserelin was as effective as chemotherapy +/- goserelin for treatment of ER-positive, but not ER-negative, breast cancer

Evidence-based obstetrics and gynecology, 2004-12, Vol.6 (4), p.208-209

2004

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen to raloxifene and beyond: Breast cancer. I

Seminars in oncology, 2001, Vol.28 (3), p.260-273

2001

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen after breast cancer reduces the risk of cancer in the second breast in BRCA1 and BRCA2 carriers

Evidence-based obstetrics and gynecology, 2001-09, Vol.3 (3), p.154-155

O'Regan, Ruth M.

2001

Link zum Volltext

Verfügbarkeit prüfen

Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182-780 on endometrial cancer growth / Response

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (8), p.722

1999

Link zum Volltext

Verfügbarkeit prüfen

Response: Re: Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (8), p.722a-723

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Treatment And Research

ThemaBreast Cancer

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry

Insulin-like Growth Factor-l-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells

Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth

Abstract 590: Multiplex liquid biopsy for AR pathway activity in metastatic androgen receptor-positive triple negative breast cancer

Abstract PS5-35: Detection of PI3K pathway activation in circulating tumor cells in PIK3CA mutated metastatic breast cancer as a putative predictive biomarker for PI3K inhibitor therapies

In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots

Abstract P5-07-07: Combination of IGF1R/FAK inhibition and PI3K/mTOR inhibition in triple-negative breast cancers

Abstract A07: Spontaneous canine mammary cancers: A much-needed model for human basal-like breast cancer and an ideal system to understand myoepithelial cells

Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy

Abstract 1955: Simultaneous longitudinal assessment of PIK3CA genomic mutations and PI3K pathway activity in circulating tumor cells in metastatic breast cancer

Abstract 1467: Inhibition of Cdk4 radiosensitizes breast cancer cells by increasing PP2A levels, and decreasing Bad136 phosphorylation

Abstract 2703: Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer

Abstract LB-206: Breast cancer 21 -gene recurrence scores: Are there racial disparities in testing, scores, treatment, and outcome

Tamoxifen to raloxifene and beyond

Abstract CT051: Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Goserelin was as effective as chemotherapy +/- goserelin for treatment of ER-positive, but not ER-negative, breast cancer

Tamoxifen to raloxifene and beyond: Breast cancer. I

Tamoxifen after breast cancer reduces the risk of cancer in the second breast in BRCA1 and BRCA2 carriers

Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182-780 on endometrial cancer growth / Response

Response: Re: Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth

Aktive Filter

Suchergebnisse filtern